Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study.
BACKGROUND
In Huntington disease (HD), substantial striatal atrophy precedes clinical motor symptoms. Accordingly, neuroprotection should prevent major cell loss before such symptoms arise. To evaluate neuroprotection, biomarkers such as MRI measures are needed. This requires first establishing the best imaging approach.


METHODS
Using a cross-sectional design, we acquired T1-weighted and diffusion-weighted scans in 39 preclinical (pre-HD) individuals and 25 age-matched controls. T1-weighted scans were analyzed with gross whole-brain segmentation and voxel-based morphometry. Analysis of diffusion-weighted scans used skeleton-based tractography. For all imaging measures, we compared pre-HD and control groups and within the pre-HD group we examined correlations with estimated years to clinical onset.


RESULTS
Pre-HD individuals had lower gross gray matter (GM) and white matter (WM) volume. Voxel-wise analysis demonstrated local GM volume loss, most notably in regions consistent with basal ganglia-thalamocortical pathways. By contrast, pre-HD individuals showed widespread reductions in WM integrity, probably due to a loss of axonal barriers. Both GM and WM imaging measures correlated with estimated years to onset.


CONCLUSIONS
Using automated, observer-independent methods, we found that GM loss in pre-HD was regionally specific, while WM deterioration was much more general and probably the result of demyelination rather then axonal degeneration. These findings provide important information about the nature, relative staging, and topographic specificity of brain changes in pre-HD and suggest that combining GM and WM imaging may be the best biomarker approach. The empirically derived group difference images from this study are provided as regions-of-interest masks for improved sensitivity in future longitudinal studies.
Stoffers
D
D
Department of Psychology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0109, USA.
Sheldon
S
S
Kuperman
J M
JM
Goldstein
J
J
Corey-Bloom
J
J
Aron
A R
AR
D000328:Adult; D001921:Brain / Q000473:pathology*; D001931:Brain Mapping; D016009:Chi-Square Distribution; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000473:pathology*; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009413:Nerve Fibers, Myelinated / Q000473:pathology*; D036421:Nerve Fibers, Unmyelinated / Q000473:pathology*
J Comput Assist Tomogr. 2001 May-Jun;25(3):466-75
11351200
Neurology. 2004 Jul 13;63(1):66-72
15249612
Mov Disord. 2006 Sep;21(9):1317-25
16755582
Neuroimage. 2006 Jul 15;31(4):1487-505
16624579
Psychiatry Res. 2005 Oct 30;140(1):55-62
16199141
Radiology. 2004 Sep;232(3):867-73
15215553
Neuroimage. 2001 Dec;14(6):1454-62
11707101
Annu Rev Neurosci. 1986;9:357-81
3085570
Neurology. 2004 Apr 27;62(8):1432-4
15111692
Arch Neurol. 2006 Jun;63(6):883-90
16769871
Brain. 2002 Aug;125(Pt 8):1815-28
12135972
Hum Brain Mapp. 2009 May;30(5):1535-47
18671230
Neuroimage. 2006 Sep;32(3):1090-9
16765064
Clin Genet. 2004 Apr;65(4):267-77
15025718
Neuroimage. 2009 Jan 1;44(1):83-98
18501637
Neuroimage. 2006 Apr 1;30(2):436-43
16300968
Neuroimage. 2000 Jun;11(6 Pt 1):805-21
10860804
Mov Disord. 2000 May;15(3):552-60
10830423
Brain. 2008 Jan;131(Pt 1):196-204
18056161
Biol Psychiatry. 2006 Jan 1;59(1):57-63
16112655
Arch Neurol. 1996 Dec;53(12):1293-6
8970459
Am J Psychiatry. 2007 Sep;164(9):1428-34
17728429
Mov Disord. 1996 Mar;11(2):136-42
8684382
Neurotherapeutics. 2008 Apr;5(2):226-36
18394565
Ann Neurol. 2001 Jan;49(1):29-34
11198293
Neuroimage. 2002 Sep;17(1):479-89
12482100
Exp Neurol. 2009 Apr;216(2):525-9
19320010
Brain. 1999 Sep;122 ( Pt 9):1667-78
10468506
Neurochem Res. 2007 Oct;32(10):1655-64
17484051
J Int Neuropsychol Soc. 1998 Sep;4(5):467-73
9745236
Neuroimage. 2004;23 Suppl 1:S208-19
15501092
Nat Rev Neurosci. 2004 May;5(5):373-84
15100720
Neuroimage. 2001 Dec;14(6):1238-43
11707080
Hum Brain Mapp. 2002 Jan;15(1):1-25
11747097
Brain Res Rev. 2008 Jun;58(1):209-25
18486229
J Neurol Neurosurg Psychiatry. 2005 May;76(5):650-5
15834021
Neuroimage. 2002 Nov;17(3):1429-36
12414282
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
12489094
Neurology. 1994 May;44(5):823-8
8190282